The use of bemitil in patients with progressive muscular dystrophies
Lobzin, V.S.; Saĭkova, L.A.; Chukhlovina, M.L.; Pustozerov, V.G.
Likars'ka Sprava 4: 85-87
1992
ISSN/ISBN: 1019-5297 PMID: 1441389 Document Number: 4780
Bemithyl treatment was carried out in 22 patients with neuromuscular diseases (progressive myodystrophy). The actoprotector bemithyl inhibited in these patients the processes of lipid peroxidation, activation of neoglucogenesis favours improvement of interorganic exchange of metabolites. Bemithyl is recommended in patients with progressive myodystrophy along with drugs normalizing the protein, energy and electrolyte metabolism.
Document emailed within 1 workday
